| |
| |
|
| Insider
Information: |
Burrows Scott L |
| Relationship: |
|
| City: |
Westlake Village |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
194,068 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$555,169 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
194,068 |
|
|
| Total
Value |
$555,169 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
Chief Financial Officer |
2023-03-06 |
59,115 |
2021-12-27 |
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2023-12-22 |
134,953 |
2023-12-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer |
• – – |
2023-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
134,953 |
134,953 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2023-03-06 |
4 |
AS |
$15.26 |
$4,442 |
D/D |
(291) |
59,115 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
59,406 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
AS |
$15.82 |
$22,696 |
D/D |
(1,434) |
38,406 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
AS |
$16.17 |
$6,725 |
D/D |
(416) |
39,840 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2022-09-16 |
4 |
OE |
$1.68 |
$8,403 |
D/D |
5,000 |
40,256 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2022-03-07 |
4 |
AS |
$16.44 |
$164 |
D/D |
(10) |
35,256 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2022-03-04 |
4 |
AS |
$16.86 |
$4,940 |
D/D |
(293) |
35,266 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,300 |
35,559 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
AS |
$17.75 |
$7,456 |
D/D |
(420) |
22,259 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
• – – |
2021-12-27 |
4 |
AS |
$20.07 |
$252,139 |
D/D |
(12,560) |
22,679 |
0 |
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
